Soluble Ferric Pyrophosphate

DRUG3 trials

Sponsors

Rockwell Medical Technologies, Inc.

Conditions

End-Stage Renal Disease (ESRD)Kidney FailureKidney Failure, Chronic Therapy; Hemodialysis

Phase 1

Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients

CompletedNCT01894906

Rockwell Medical Technologies, Inc.Kidney Failure

Start: 2013-07-31End: 2013-09-30Updated: 2015-02-16

A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers.

CompletedNCT01920854

Rockwell Medical Technologies, Inc.Kidney Failure, Chronic Therapy; Hemodialysis

Start: 2013-06-30End: 2013-09-30Updated: 2015-01-26

Phase 2

Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis

CompletedNCT00548249

Rockwell Medical Technologies, Inc.End-Stage Renal Disease (ESRD)

Start: 2007-08-31End: 2010-01-31Updated: 2020-12-02